A number of start-ups and major tech companies like Microsoft, Ticketmaster, Apple, and Google are interested in vaccine or immunization passports to help reopen the economy. But public health officials are weary, warning the apps are pointless without more knowledge about the efficacy of the vaccines. Watch the video above to learn more about digital vaccine verifications and how you could possibly prove your immunity to coronavirus before attending an event or entering a building.
Messenger RNA—or mRNA—vaccines have been in development for decades, and are now approved for use against COVID-19. Here’s how they work and what you should know about them. Visit https://www.jhsph.edu/covid-19 for even more resources.
Join CNET during CES 2021 for talks with three medical luminaries to discuss what we’ve gained — and need to fix — with telehealth over a turbulent pandemic year.
Israel says it’s on track to vaccinate everyone over 16 by the end of March. To understand how the small country has vaccinated more of its population than any other so quickly, WSJ visited clinics that are giving shots to young and middle-aged citizens. Photo: Tamir Elterman for The Wall Street Journal
Making changes in the way you eat can be difficult. Learn about small steps for healthy eating to help you manage your weight. For more information, visit https://www.niddk.nih.gov/health-info…
This video tells the story of Ana, a cervical cancer survivor, who encourages women to recognize abnormal Paps as an opportunity to speak to your doctor about gynecologic health.
Walmart, America’s largest grocer, launched a primary care clinic called Walmart Health, in September 2019. Analysts say the big box retailer faces several hurdles in its quest to scale up nationally with a roster of highly paid doctors and dentists. But with more than 35 million people uninsured as of 2019, and millions more with high deductible health plans, could Walmart Health’s low price point be the future of healthcare in America?
The common cold is the most common human disease in the world. So, why haven’t we found a cure yet?!
Called human rhinoviruses, these respiratory viruses measure between 15 to 30 nanometers in diameter, making them some of the smallest types of viruses out there. And it’s partly thanks to the viruses’ genetic makeup that they’re so good at replicating.
Human rhinoviruses travel like most other respiratory viruses via nasal secretions, which can be released through sneezing, or through contact with fomites, which are surfaces like a keyboard or a doorknob that can help spread the virus from one person to another. From there, all it takes is for a hand to touch one of the body’s mucous membranes like the eyes, nose, or mouth and bam — the virus has gained entry.
Soon after infection, coughing, sneezing, headaches, a mild fever and body aches can soon follow. And these symptoms may easily be confused with those of the flu. But unlike the flu, where symptoms start quite suddenly, it can take a couple of days for cold symptoms to fully develop. And they usually last anywhere from 7 to 14 days.
Our skin is home to billions of microorganisms, the vast majority of which are bacteria. Much like the microbiome in our gut, these microbes play a crucial part in keeping us healthy. They are part of a finely balanced ecosystem of friendly or ‘commensal’ bacteria, which protect our skin by creating an inhospitable environment for would-be invaders, bolstering the physical integrity of the skin, and training the immune system to distinguish commensal inhabitants from pathogens. A number of skin conditions are now understood to be influenced by a breakdown of this microbial ecosystem. Researchers are working out whether restoring the balance can treat these conditions. Understanding the ecology of this rich community is likely to be an important part of both dermatology and the study of the microbiome. Read more in https://www.nature.com/collections/sk…
As states and hospitals in the U.S. race to roll out the first Covid-19 vaccines, WSJ’s Daniela Hernandez hears from a hospital administrator and immunization expert about the logistical challenges involved in this first phase of the vaccination process.
Photo: Victoria Jones/Zuma Press